Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BMY Bristol-Myers Squibb	$57.71 -3.2%	$58.74	$39.35 ▼ $63.33	$117.42B	0.43	12.74 million shs	13.23 million shs
CVS CVS Health	$67.44 -0.9%	$63.02	$43.56 ▼ $75.27	$85.03B	0.54	11.53 million shs	12.20 million shs
TRIP Tripadvisor	$12.98 -9.3%	$15.77	$12.93 ▼ $28.15	$1.82B	1.35	2.39 million shs	4.20 million shs

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BMY Bristol-Myers Squibb	+0.10%	+0.70%	-0.43%	+4.93%	+12.97%
CVS CVS Health	+0.38%	+1.46%	+5.12%	+54.09%	-7.69%
TRIP Tripadvisor	+2.00%	-5.17%	-0.56%	-4.54%	-48.38%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BMY Bristol-Myers Squibb	3.8312 of 5 stars	1.2	3.0	4.2	4.0	3.5	3.3	0.0
CVS CVS Health	4.8709 of 5 stars	2.5	4.0	3.3	3.9	2.9	3.3	3.1
TRIP Tripadvisor	4.133 of 5 stars	4.0	3.0	0.0	1.6	1.6	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BMY Bristol-Myers Squibb	2.33	Hold	$57.86	0.26% Upside
CVS CVS Health	2.90	Moderate Buy	$70.41	4.41% Upside
TRIP Tripadvisor	1.93	Reduce	$17.57	35.37% Upside

Current Analyst Ratings Breakdown

Latest BMY, CVS, and TRIP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/21/2025	CVS CVS Health	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$72.00 ➝ $74.00
3/10/2025	TRIP Tripadvisor	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$20.00 ➝ $18.00
2/21/2025	TRIP Tripadvisor	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$14.00 ➝ $13.00
2/21/2025	TRIP Tripadvisor	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underweight ➝ Underweight	$14.00 ➝ $15.00
2/20/2025	TRIP Tripadvisor	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$16.00 ➝ $16.00
2/18/2025	CVS CVS Health	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$77.00
2/18/2025	CVS CVS Health	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$80.00 ➝ $81.00
2/13/2025	CVS CVS Health	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$68.00 ➝ $73.00
2/13/2025	CVS CVS Health	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$60.00 ➝ $76.00
2/13/2025	CVS CVS Health	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$71.00 ➝ $73.00
2/13/2025	CVS CVS Health	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$55.00 ➝ $75.00

(Data available from 4/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BMY Bristol-Myers Squibb	$48.30B	2.43	$6.09 per share	9.48	$8.08 per share	7.14
CVS CVS Health	$372.81B	0.23	$9.42 per share	7.16	$60.06 per share	1.12
TRIP Tripadvisor	$1.84B	0.99	$0.94 per share	13.77	$6.77 per share	1.92

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BMY Bristol-Myers Squibb	-$8.95B	-$4.42	N/A	9.48	2.07	-18.53%	13.93%	2.46%	4/24/2025 (Estimated)
CVS CVS Health	$4.61B	$3.66	18.43	9.96	0.98	1.24%	9.11%	2.71%	4/29/2025 (Estimated)
TRIP Tripadvisor	$10M	$0.02	649.32	21.63	9.01	0.33%	9.02%	2.98%	5/6/2025 (Estimated)

Latest BMY, CVS, and TRIP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/24/2025	N/A	BMY Bristol-Myers Squibb	$1.55	N/A	N/A	N/A	$10.77 billion	N/A
2/20/2025	Q4 2024	TRIP Tripadvisor	$0.21	$0.13	-$0.08	$0.01	$400.02 million	$411.00 million
2/12/2025	Q4 2024	CVS CVS Health	$0.89	$1.19	+$0.30	$1.30	$96.90 billion	N/A
2/6/2025	Q4 2024	BMY Bristol-Myers Squibb	$1.47	$1.67	+$0.20	$0.04	$11.57 billion	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BMY Bristol-Myers Squibb	$2.48	4.30%	+6.38%	N/A	17 Years
CVS CVS Health	$2.66	3.94%	+9.97%	72.68%	N/A
TRIP Tripadvisor	N/A	N/A	N/A	N/A	N/A

Latest BMY, CVS, and TRIP Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/3/2025	BMY Bristol-Myers Squibb	quarterly	$0.62	4.14%	4/4/2025	4/4/2025	5/1/2025
3/20/2025	CVS CVS Health	quarterly	$0.6650	3.89%	4/22/2025	4/22/2025	5/1/2025
1/3/2025	CVS CVS Health	quarterly	$0.6650	6.02%	1/23/2025	1/23/2025	2/3/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BMY Bristol-Myers Squibb	2.90	1.25	1.15
CVS CVS Health	0.80	0.81	0.60
TRIP Tripadvisor	0.93	2.10	1.85

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BMY Bristol-Myers Squibb	76.41%
CVS CVS Health	80.66%
TRIP Tripadvisor	98.99%

Insider Ownership

Company	Insider Ownership
BMY Bristol-Myers Squibb	0.09%
CVS CVS Health	0.24%
TRIP Tripadvisor	2.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BMY Bristol-Myers Squibb	34,300	2.03 billion	2.03 billion	Optionable
CVS CVS Health	300,000	1.26 billion	1.26 billion	Optionable
TRIP Tripadvisor	3,100	140.38 million	136.27 million	Optionable

BMY, CVS, and TRIP Headlines

Recent News About These Companies

Highest-rated cafés in Cleveland by diners, according to Tripadvisor

April 3 at 12:31 AM | cleveland.com

From mountains to the beach, here are Tripadvisor's top 5 spring break resorts in Georgia

April 2 at 7:29 PM | yahoo.com

Wall Street Analysts Believe TripAdvisor (TRIP) Could Rally 27.01%: Here's is How to Trade

April 2 at 11:01 AM | zacks.com

Mitsubishi UFJ Trust & Banking Corp Boosts Stake in Tripadvisor, Inc. (NASDAQ:TRIP)

April 2 at 4:06 AM | marketbeat.com

TripAdvisor (TRIP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

April 1 at 11:00 AM | zacks.com

WINTON GROUP Ltd Buys 33,635 Shares of Tripadvisor, Inc. (NASDAQ:TRIP)

March 31 at 4:20 AM | marketbeat.com

Best spring retreats in Northumberland - Tripadvisor

March 30, 2025 | hexham-courant.co.uk

Best Dorset Michelin Guide restaurants according to Tripadvisor

March 30, 2025 | msn.com

Top 10 parks to visit on National Take a Walk in the Park Day, according to TripAdvisor

March 30, 2025 | msn.com

203,747 Shares in Tripadvisor, Inc. (NASDAQ:TRIP) Bought by Raymond James Financial Inc.

March 30, 2025 | marketbeat.com

Boussard & Gavaudan Investment Management LLP Buys 19,980 Shares of Tripadvisor, Inc. (NASDAQ:TRIP)

March 29, 2025 | marketbeat.com

Three California cities rank in Tripadvisor's best 2025 U.S. travel destination list

March 29, 2025 | yahoo.com

The Top 10 Beaches In The U.S.—According To A 2025 Tripadvisor Report

March 29, 2025 | forbes.com

Perplexity partners with Selfbook, Tripadvisor to offer hotel booking

March 27, 2025 | travelweekly.com

This Nevada town was named one of the best travel destinations in Tripadvisor's 2025 awards

March 27, 2025 | usatoday.com

Trade Tracker: Jenny Harrington buys more Disney and Tripadvisor

March 26, 2025 | youtube.com

Liberty TripAdvisor Announces Merger with Tripadvisor

March 24, 2025 | tipranks.com

This Palm Beach County city is on Tripadvisor's Best of the Best destinations for 2025

March 24, 2025 | palmbeachpost.com

Tripadvisor, Inc. (NASDAQ:TRIP) Receives $17.57 Average Target Price from Analysts

March 24, 2025 | americanbankingnews.com

Royce & Associates LP Purchases 18,540 Shares of Tripadvisor, Inc. (NASDAQ:TRIP)

March 23, 2025 | marketbeat.com

Palogic Value Management L.P. Sells 30,000 Shares of Tripadvisor, Inc. (NASDAQ:TRIP)

March 22, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Warren Buffett Swaps VOO for This Reliable Dividend Stock
By Sarah Horvath | March 7, 2025
View Warren Buffett Swaps VOO for This Reliable Dividend Stock
NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
By Thomas Hughes | March 12, 2025
View NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
By Jeffrey Neal Johnson | March 21, 2025
View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
3 Defense Stocks Set to Benefit From Increased Military Spending
By Chris Markoch | March 20, 2025
View 3 Defense Stocks Set to Benefit From Increased Military Spending
4 Healthcare Stocks With Massive Gains—and More to Come
By Sarah Horvath | March 29, 2025
View 4 Healthcare Stocks With Massive Gains—and More to Come

BMY, CVS, and TRIP Company Descriptions

Bristol-Myers Squibb NYSE:BMY

$57.70 -1.90 (-3.18%)

Closing price 03:59 PM Eastern

Extended Trading

$57.90 +0.20 (+0.34%)

As of 06:19 PM Eastern

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

CVS Health NYSE:CVS

$67.44 -0.63 (-0.93%)

Closing price 03:59 PM Eastern

Extended Trading

$67.44 0.00 (0.00%)

As of 06:19 PM Eastern

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Tripadvisor NASDAQ:TRIP

$12.98 -1.33 (-9.29%)

Closing price 04:00 PM Eastern

Extended Trading

$12.99 +0.01 (+0.08%)

As of 06:17 PM Eastern

TripAdvisor, Inc. operates as an online travel company, primarily engages in the provision of travel guidance products and services worldwide. The company operates in three segments: Brand Tripadvisor, Viator, and TheFork. The Brand Tripadvisor segment offers travel guidance platforms for travelers to discover, generate, and share authentic user-generated content in the form of ratings and reviews for destinations, points-of-interest, experiences, accommodations, restaurants, and cruises. The Viator's segment provides pure-play experiences online travel agency that comprehensive and connecting travelers to discover and book tours, activities, and attractions from experience operators. TheFork segment provides an online marketplace that enables diners to discover and book online reservations at restaurants. TripAdvisor, Inc. was founded in 2000 and is headquartered in Needham, Massachusetts. Tripadvisor, Inc. is a subsidiary of Liberty TripAdvisor Holdings, Inc.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time